Topics

Companies Related to "Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic" [Most Relevant Company Matches] RSS

12:10 EST 22nd January 2020 | BioPortfolio

Here are the most relevant search results for "Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic" found in our extensive corporate database of over 50,000 company records.

Showing "Evaluating Metabolic Effects Polylactose Novel Prebiotic" Companies 1–25 of 764

Relevant

Metabolic Solutions Development Company

Metabolic Solutions Development Company (www.msdrx.com), based in Kalamazoo, Mich., is developing innovative therapeutics using a different pharmacological path to treat type 2 diabetes and related metabolic diseases. This new approach seeks to improve the efficacy of treatment and free patients from the adverse side effects of current treatments, including edema and weight gain.


Limerick BioPharma, Inc.

Limerick BioPharma (http://www.limerickbio.com) is developing small molecule modulators of cell membrane-bound transporters to rid cells of unwanted toxins. By activating cellular transport pumps to redistribute drugs away from organs and tissues where they have adverse effects, the company’s proprietary Activators minimize toxic side effects at non-t...

ChanTest Inc.

To provideNon-Clinical drug safety testing and discovery services that accelerate drug development by:Leveraging our extensive experience in evaluating drug-induced effects on ion channels, purkinje fibers, and iolated hearts; Providing accurate, repeatable results; Consistently responding with a high sense of urgency


Ember Therapeutics, Inc.

Ember Therapeutics is a product-focused company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease. Today’s rising epidemic of obesity and Type 2 diabetes coupled with the lack of innovation in the industry’s metabolic disorder treatment pipeline underscores the need for novel, ...

Ember Therapeutics

Ember Therapeutics is a product-focused company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease. Today’s rising epidemic of obesity and Type 2 diabetes coupled with the lack of innovation in the industry’s metabolic disorder treatment pipeline underscores the need for novel, ...

Oregon Osteoporosis Center

The Oregon Osteoporosis Center was founded in 1980 and has two locations in Portland, Oregon, one in Vancouver, Washington, and one in Salem, Oregon. The Center provides a comprehensive program focusing on the evaluation and management of patients with osteoporosis, with four major components:A consultative clinic for the care of patients with or at risk for osteoporosis and other metabolic bone d...

METabolic EXplorer S.A.

METabolic EXplorer develops and applies cutting edge tools of biotechnology to design new biosynthetic pathways for the efficient and cost-effective production of valuable chemicals.METabolic EXplorer provides the chemical and life science industry with cost-effective innovative solutions for the manufacturing of their chemicals by fermentation.METabolic EXplorer creates new whole-cell biotransfor...

GTX

GTx, Inc., headquartered in Memphis, Tennessee, is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel hormonal therapeutics for cancer and serious conditions related to men’s health. GTx's lead drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens. GTx is developing...

Peptimmune,Inc

Peptimmune's metabolic disease expertise is based upon polymer chemistry technologyand related ntellectual property assets. Peptimmune is using non-absorbable hydrogelpolymers as fat binding agents to improve the tolerability of lipase inhibitors for thetreatment of obesity. The polymer technology utilizes a proprietary polymer thateliminates fat coalescence. A drug candidate has been identified w...

BiomeBliss

Developed by MicroBiome Therapeutics LLC, BiomeBliss is a patented prebiotic dietary supplement designed to nourish, shift and protect the microbiome of the human digestive system. A powdered drink mix, BiomeBliss is made from natural plant-based ingredients. Clinical test results show BiomeBliss helps control hunger, promotes regularity, supports overall ...

Integrated Genomics, Inc.

Integrated Genomics (www.integratedgenomics.com) is a provider of bioinformatics products and services for the life sciences industry. The company’s expertise in microbial genomics includes genome sequencing, comparative genomics and custom bioinformatics applications. IG has developed and distributes ERGO™, the most advanced and comprehensive bi...

Proteostasis Therapeutics

Proteostasis Therapeutics is discovering “Proteostasis Regulators” (PRs), small molecule drugs that restore proper protein function to treat neurodegenerative, metabolic, genetic and inflammatory disorders. The Proteostasis Network (PN) is the cellular machinery responsible for protein folding, trafficking and clearance, and it can become imbalanced ...

Consumer Effects International

Pink Ribbon Produce is developed and executed by Consumer Effects International, a leading consumer marketing agency for the retail and produce industries. With a highly developed knowledge base in retail marketing, merchandising, supply sell-in and public relations, Consumer Effects develops retailer specific custom sales campaigns nationwide. Their efforts focus on driving the consumption of fru...

Chronogen, Inc.

With an aging population, the prevalence of age-related diseases is expected to mount rapidly over the next decade and new drugs are needed. Cardiovascular and metabolic diseases, cancer, neurodegenerative diseases represent huge markets that Biotech and Pharma companies are targeting. Initially, Chronogen has focused all activities on the identification and the characterization of longevity targe...

KineMed, Inc.

KineMed, Inc. ("KineMed" or the "Company") is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag™ and KineMarker™) to both identify active drug candidates preclinically and confirm their therapeutic activity and dose response in first-in-man studies. The Company is working to develop drug...

AstraZeneca and Bristol-Myers Squibb

Dedicated to addressing the global burden of diabetes by advancing individualized patient care, AstraZeneca and Bristol-Myers Squibb are working in collaboration to research, develop and commercialize a versatile portfolio of innovative treatment options for diabetes and related metabolic disorders that aim to provide treatment effects beyond glucose contr...

AstraZeneca and Bristol-Myers Squibb Company

Dedicated to addressing the global burden of diabetes by advancing individualized patient care, AstraZeneca and Bristol-Myers Squibb are working in collaboration to develop and commercialize a versatile portfolio of innovative treatment options for diabetes and related metabolic disorders that aim to provide treatment effects beyond glucose control. Find o...

Outcomes Pharmaceutical Health Care

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides services and technologies focused on evaluating the safety, effectiveness, and quality of healthcare products and services. The company has designed, developed, and managed an industr...

MEBIAS Discovery LLC

MEBIAS, an emerging leader in the field of biased agonism GPCR drug discovery, was founded by three highly experienced drug discovery scientists, formerly of Merck and Johnson & Johnson. MEBIAS has developed a platform to discover next-generation GPCR drugs that avoid the on-target side effects of earlier generations of compounds, which historically signal...

Proteostasis Therapeutics and Elan Corporation

Proteostasis Therapeutics is developing “Proteostasis Regulators” (PRs), small molecule drugs that restore proper protein function or remove misfolded and aggregated proteins to treat neurodegenerative, metabolic, genetic and inflammatory disorders. The Proteostasis Network is the cellular machinery responsible for protein folding, trafficking and ...

ORIDIS Biomed GmbH

ORIDIS™ Biomed is a biomedical company focusing on the discovery and development of therapeutics and targeted treatment solutions for liver cancer and metabolic diseases of the liver.ORIDIS™ Biomed has built a potent drug discovery and development organization based on its extensive scientific and clinical expertise in the area of liver disease, its proprietary TISSOMICS™ research engine, an...

Tau Therapeutics LLC

Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel – a novel mechanism of action for cancer. The company’s approach, called Interlaced Therapy™, capitalizes on the central role of calcium influx through T-type calcium channels during cancer cell growth. T-type ...

Probably Relevant

Outcome Sciences, Inc.

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides services and technologies focused on evaluating the safety, effectiveness, and quality of healthcare products and services. The company has designed, developed, and managed more than ...

Zentrum BATS

BATS Centre is a leading competence center studying the effects of biotechnology.The main application of biotechnology is in farming (green biotechnology) and medicine (red biotechnology). Looking forward, the BATS Centre analyses possible effects on economy, ecology and society.We are heading towards the following goals:

Catabasis Pharmaceuticals

Catabasis is dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. The company has assembled a team of passionate and experienced scientists who are committed to improving the lives of patients. Using its proprietary Catabasis SMART-linker technology, Catabasis has developed a p...


More From BioPortfolio on "Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic"

Quick Search

Corporate Database Quicklinks